17Aug 2023
Lupin gets USFDA nod for Bromfenac Ophthalmic Solution

Lupin gets USFDA nod for Bromfenac Ophthalmic Solution

Lupin, a pharmaceutical company, has gained approval from the US FDA to market its generic Bromfenac Ophthalmic Solution, used for inflammation after cataract surgery. This approval pertains to the 0.09% concentration. This product is equivalent to Bausch + Lomb's Bromday Ophthalmic Solution. Manufactured in their Madhya Pradesh facility, it had an estimated annual US sales of $11 million, according to IQVIA MAT data for June.

  • #family health

Like

Save

Share